Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Haemophilus influenzae type B
2022
2007
Europe
Western Pacific
Clear all
Type of publications
NITAG documentation
(38)
Systematic reviews (SYSVAC)
(14)
Topics
Available to download in languages
Regions
Europe
(35)
Western Pacific
(17)
Africa
(23)
Americas
(41)
Eastern Mediterranean
(3)
South-East Asia
(1)
Countries
Australia
(11)
Belgium
(5)
China
(6)
France
(9)
Germany
(2)
Ireland
(4)
Italy
(1)
Netherlands
(2)
Spain
(1)
Ukraine
(1)
United Kingdom
(6)
Diseases
COVID-19
(51)
Haemophilus influenzae type B
(1)
Hepatitis B
(1)
Herpes zoster
(3)
Human papillomavirus (HPV)
(11)
Influenza
(8)
Japanese encephalitis
(1)
Meningococcal disease
(1)
Mpox // Monkeypox
(9)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Rotavirus
(2)
Tick-borne encephalitis
(1)
Vaccine topics
Acceptance
(7)
Coverage
(4)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Ethical issues
(4)
Safety
(1)
Target population
Adolescents
(3)
Adults
(6)
All age groups
(7)
Children
(5)
Healthcare workers
(4)
Newborn
(2)
Older adults
(3)
Parents/caregivers
(3)
Pregnant women
(1)
Travellers
(1)
Publication date
2022
(51)
2007
(1)
2024
(1)
2023
(19)
2021
(90)
2020
(36)
2019
(1)
2017
(1)
2015
(3)
2013
(2)
2010
(3)
2005
(1)
52 results found
2022
∙
ATAGI
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
2022
∙
ATAGI
ATAGI recommendations on the use of a booster dose of COVID-19 vaccine
2022
∙
ATAGI
ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination
2022
∙
ATAGI
ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine
2022
∙
ATAGI
ATAGI updated recommendations for a winter dose of COVID-19 vaccine
2022
∙
Conseil Supérieur de la Santé (CSS)
Booster vaccination for children and adolescents
2022
∙
Conseil Supérieur de la Santé (CSS)
Booster vaccination for immunocompromised patients
2022
∙
Conseil Supérieur de la Santé (CSS)
COVID-19 vaccination: Autumn / Winter season 2022 – 2023 in Belgium
2022
∙
Health Council of the Netherlands
Executive summary of the Second booster vaccination against COVID-19
2022
∙
ATAGI
Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register